Filing Flows › Cryo Cell International (CCEL) › Q3 FY26 › vs Q3 FY25
Cryo Cell International (CCEL) Q3 FY26 vs Q3 FY25 (year over year)
Cryo Cell International's revenue fell $1K (0%) from $7.8M in Q3 FY25 to $7.8M in Q3 FY26. The biggest changes: Processing and Storage Fees −$171K (-2%); Public Banking +$131K (33×); Product +$38K (89×). Operating margin 28.0% against 24.3% (+3.8 pts).
Cryo Cell International, Q3 FY26: revenue $7.8M (0% year over year), operating margin 28.0%, net earnings $1.3M, operating cash flow $1.1M. The chart draws each line against Q3 FY25, the increases inside each band.
Margins
| Q3 FY26 | Q3 FY25 | Change | |
|---|---|---|---|
| Operating margin | 28.0% | 24.3% | +3.8 pts |
| Net margin | 16.2% | 9.6% | +6.7 pts |
| Free cash flow margin | 13.3% | 31.9% | -18.6 pts |
Every line
| Line | Q3 FY26 | Q3 FY25 | Change | % |
|---|---|---|---|---|
| Processing and Storage Fees | $7.7M | $7.8M | −$171K | -2% |
| Public Banking | $135K | $4K | $131K | 33× |
| Product | $39K | $436 | $38K | 89× |
| Revenue | $7.8M | $7.8M | −$1K | 0% |
| Operating profit | $2.2M | $1.9M | $293K | +15% |
| Costs & expenses | $5.6M | $5.9M | −$294K | -5% |
| Pre-tax earnings | $1.8M | $1.2M | $639K | +54% |
| Other expense, net | $368K | $715K | −$346K | -48% |
| Cost of revenue | $1.6M | $1.8M | −$188K | -10% |
| Research & development | $54K | $62K | −$8K | -13% |
| SG&A | $3.8M | $3.9M | −$97K | -3% |
| Other operating costs | $184K | $186K | −$1K | -0.7% |
| Net earnings | $1.3M | $749K | $521K | +70% |
| Income tax | $555K | $437K | $118K | +27% |
| Depreciation & amortization | $241K | $244K | −$4K | -1% |
| Share-based compensation | $93K | $37K | $56K | +152% |
| Working capital & other | $462K | −$1.5M | $2.0M | — |
| Operating cash flow | $1.1M | $2.5M | −$1.4M | -55% |
| Free cash flow (OCF − capex) | $1.0M | $2.5M | −$1.5M | -58% |
| Capital expenditures | $102K | $39K | $63K | +163% |
Questions
How much did Cryo Cell International's revenue grow year over year in Q3 FY26?
Cryo Cell International's revenue fell $1K (0%) from $7.8M in Q3 FY25 to $7.8M in Q3 FY26.
What drove Cryo Cell International's revenue change in Q3 FY26?
Processing and Storage Fees −$171K (-2%); Public Banking +$131K (33×); Product +$38K (89×).